A case of monozygotic twins with primary aldosteronism: a case report.
Department of Cardiovascular Medicine, Onga Nakama Medical Association, Onga Hospital, Fukuoka, Japan.
T
T
Yoshida
Department of Internal Medicine, Uchiwa Clinic, Fukuoka, Japan.
Y
Y
Uchiwa
Department of Surgery and Executive president, Onga Nakama Medical Association, Onga Hospital, Fukuoka, Japan.
K
K
Sugimachi
Department of Endocrinology, Metabolism and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
M
M
Naruse
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D040941:Heredity; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications* / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010375:Pedigree; D010641:Phenotype; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000235:genetics; D016896:Treatment Outcome; D014430:Twins, Monozygotic / Q000235:genetics
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D000451:Mineralocorticoid Receptor Antagonists